We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-0.6%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$44.1B
AUM Growth
-$1.93B
Cap. Flow
-$863M
Cap. Flow %
-1.96%
Top 10 Hldgs %
24.82%
Holding
984
New
120
Increased
284
Reduced
350
Closed
125

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$192M
2
ATVI
Activision Blizzard
ATVI
+$151M
3
DOV icon
Dover
DOV
+$127M
4
HON icon
Honeywell
HON
+$123M
5
CVX icon
Chevron
CVX
+$107M

Sector Composition

Rank Sector Weight
1 Technology 25.68%
2 Healthcare 17.44%
3 Financials 11.47%
4 Consumer Discretionary 9.72%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PODD icon
701
Insulet
PODD
$9.65B
$3.41M 0.01%
21,377
+2,646
+14% +$592K
BWA icon
702
BorgWarner
BWA
$13.5B
$3.38M 0.01%
83,706
-181,557
-68% -$7.69M
PTCT icon
703
PTC Therapeutics
PTCT
$5.91B
$3.36M 0.01%
150,000
-528,247
-78% -$19.6M
IP icon
704
International Paper
IP
$21.5B
$3.33M 0.01%
93,992
-251,800
-73% -$8.56M
BAX icon
705
Baxter International
BAX
$14B
$3.27M 0.01%
86,720
-917,227
-91% -$39.1M
X
706
DELISTED
US Steel
X
$3.25M 0.01%
+100,000
New +$2.8M
OGN icon
707
Organon & Co
OGN
$3.56B
$3.23M 0.01%
186,200
EPIX
708
DELISTED
ESSA Pharma
EPIX
$3.22M 0.01%
1,042,531
RARE icon
709
Ultragenyx Pharmaceutical
RARE
$2.54B
$3.21M 0.01%
90,000
-17,600
-16% -$697K
IMGN
710
DELISTED
Immunogen Inc
IMGN
$3.17M 0.01%
200,000
-450,000
-69% -$7.48M
AEVA
711
Aeva Technologies
AEVA
$1.73B
$3.16M 0.01%
825,577
SYM icon
712
Symbotic
SYM
$5.04B
$3.15M 0.01%
+94,150
New +$3.87M
EFX icon
713
Equifax
EFX
$20.7B
$3.11M 0.01%
17,000
-40,200
-70% -$8.21M
AVB icon
714
AvalonBay Communities
AVB
$26.6B
$3.06M 0.01%
+17,808
New +$3.29M
BCAB icon
715
BioAtla
BCAB
$5.53M
$3.05M 0.01%
35,923
-1,976
-5% -$252K
W icon
716
Wayfair
W
$14.3B
$3.03M 0.01%
50,000
+25,000
+100% +$1.74M
SILK
717
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$3M 0.01%
200,000
+50,000
+33% +$1.04M
INVH icon
718
Invitation Homes
INVH
$18B
$2.98M 0.01%
94,081
-289,737
-75% -$9.95M
SYRS
719
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.85M 0.01%
721,914
ANVS icon
720
Annovis Bio
ANVS
$79.1M
$2.85M 0.01%
+300,000
New +$3.71M
AYX
721
DELISTED
Alteryx Inc
AYX
$2.83M 0.01%
+75,000
New +$2.69M
ARWR icon
722
Arrowhead Research
ARWR
$12.1B
$2.77M 0.01%
103,035
-15,000
-13% -$460K
BFS
723
Saul Centers
BFS
$829M
$2.77M 0.01%
+78,480
New +$2.93M
DTM icon
724
DT Midstream
DTM
$13.6B
$2.65M 0.01%
50,000
LYFT icon
725
Lyft
LYFT
$6.19B
$2.63M 0.01%
+250,000
New +$2.79M

Similar funds

Adage Capital Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Adage Capital Partners held 984 positions worth $44.1B, down 4.2% from $46B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners's Q3 2023 filing shows 120 new, 284 increased, 350 reduced and 125 closed positions. Its largest new stake was Blackstone: 705,700 shares worth $75.6M. The largest sale was Boeing, an estimated $282M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2023 buy was Blackstone: 705,700 shares worth $75.6M.
  • Adage Capital Partners added most to Emerson Electric in Q3 2023, an estimated $192M increase.
  • Adage Capital Partners's biggest Q3 2023 reduction was Boeing, cutting an estimated $282M.
  • Adage Capital Partners fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $180M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $44.1B portfolio in Q3 2023.
  • Adage Capital Partners opened 120 new positions and closed 125 in Q3 2023.
  • Adage Capital Partners's portfolio value fell 4.2% quarter-over-quarter to $44.1B.

Based on Adage Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.